Durability of collagen injection for stress urinary incontinence in women proven by transvaginal 3-dimensional ultrasound

Chasta Dawne L Bacsu, Caitlin Cunningham, Alana Christie, Philippe E. Zimmern

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: The aim of this study is to evaluate the durability of collagen injection (CI) using serial 3-dimensional (3D) transvaginal ultrasound (US) in women with sufficient improvement of stress urinary incontinence (SUI) symptoms not requiring additional treatment. Methods: After the institutional review board approval, a retrospective review of prospectively followed patients who underwent CI was conducted. Eligible patients received 3 or less consecutive CI for SUI with no reinjection afterward during the follow-up period and had a minimum follow-up of 1 year from the last CI. Serial 3D US was obtained for collagen volume and configuration at baseline (6-8 weeks postoperatively) and approximately every 12 months thereafter as clinically indicated. Results: Of 191 eligible patients from 1/99 to 6/11, 67 (35%) met the inclusion criteria. The mean age was 67 years (42-90 years) with mean follow-up from the time of last CI at 43 months (12-149 months). A total of 283 three-dimensional US were performed, with the mean of 4 (2-11) per patient. The mean number of injections was 1.4 (1-3) with a mean injected volume at 5.8 mL(2-18 mL). The volume retention rate compared with the baseline volume was 84% (12%-100%), with a decrease in mean collagen volumes between the baseline and last follow-up visit (3.2 vs 2.7 mL; P = 0.008). Collagen volume decreased by a mean of 0.11 mL for each year past the final injection (P = 0.0015) by mixed-effect model analysis. Conclusions: Although believed to be nondurable, CI was found to be objectively stable over time by transvaginal 3D US in a subset of women with durably improved SUI symptoms.

Original languageEnglish (US)
Pages (from-to)25-29
Number of pages5
JournalFemale Pelvic Medicine and Reconstructive Surgery
Volume21
Issue number1
DOIs
StatePublished - 2015

Fingerprint

Stress Urinary Incontinence
Collagen
Injections
Research Ethics Committees

Keywords

  • 3-dimensional ultrasound
  • Bulking agents
  • Collagen
  • Urethral injection
  • Urinary incontinence

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Surgery
  • Urology

Cite this

Durability of collagen injection for stress urinary incontinence in women proven by transvaginal 3-dimensional ultrasound. / Bacsu, Chasta Dawne L; Cunningham, Caitlin; Christie, Alana; Zimmern, Philippe E.

In: Female Pelvic Medicine and Reconstructive Surgery, Vol. 21, No. 1, 2015, p. 25-29.

Research output: Contribution to journalArticle

@article{1b3fb044b39042fca66d0547059d1cc8,
title = "Durability of collagen injection for stress urinary incontinence in women proven by transvaginal 3-dimensional ultrasound",
abstract = "Objective: The aim of this study is to evaluate the durability of collagen injection (CI) using serial 3-dimensional (3D) transvaginal ultrasound (US) in women with sufficient improvement of stress urinary incontinence (SUI) symptoms not requiring additional treatment. Methods: After the institutional review board approval, a retrospective review of prospectively followed patients who underwent CI was conducted. Eligible patients received 3 or less consecutive CI for SUI with no reinjection afterward during the follow-up period and had a minimum follow-up of 1 year from the last CI. Serial 3D US was obtained for collagen volume and configuration at baseline (6-8 weeks postoperatively) and approximately every 12 months thereafter as clinically indicated. Results: Of 191 eligible patients from 1/99 to 6/11, 67 (35{\%}) met the inclusion criteria. The mean age was 67 years (42-90 years) with mean follow-up from the time of last CI at 43 months (12-149 months). A total of 283 three-dimensional US were performed, with the mean of 4 (2-11) per patient. The mean number of injections was 1.4 (1-3) with a mean injected volume at 5.8 mL(2-18 mL). The volume retention rate compared with the baseline volume was 84{\%} (12{\%}-100{\%}), with a decrease in mean collagen volumes between the baseline and last follow-up visit (3.2 vs 2.7 mL; P = 0.008). Collagen volume decreased by a mean of 0.11 mL for each year past the final injection (P = 0.0015) by mixed-effect model analysis. Conclusions: Although believed to be nondurable, CI was found to be objectively stable over time by transvaginal 3D US in a subset of women with durably improved SUI symptoms.",
keywords = "3-dimensional ultrasound, Bulking agents, Collagen, Urethral injection, Urinary incontinence",
author = "Bacsu, {Chasta Dawne L} and Caitlin Cunningham and Alana Christie and Zimmern, {Philippe E.}",
year = "2015",
doi = "10.1097/SPV.0000000000000094",
language = "English (US)",
volume = "21",
pages = "25--29",
journal = "Female Pelvic Medicine and Reconstructive Surgery",
issn = "2151-8378",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Durability of collagen injection for stress urinary incontinence in women proven by transvaginal 3-dimensional ultrasound

AU - Bacsu, Chasta Dawne L

AU - Cunningham, Caitlin

AU - Christie, Alana

AU - Zimmern, Philippe E.

PY - 2015

Y1 - 2015

N2 - Objective: The aim of this study is to evaluate the durability of collagen injection (CI) using serial 3-dimensional (3D) transvaginal ultrasound (US) in women with sufficient improvement of stress urinary incontinence (SUI) symptoms not requiring additional treatment. Methods: After the institutional review board approval, a retrospective review of prospectively followed patients who underwent CI was conducted. Eligible patients received 3 or less consecutive CI for SUI with no reinjection afterward during the follow-up period and had a minimum follow-up of 1 year from the last CI. Serial 3D US was obtained for collagen volume and configuration at baseline (6-8 weeks postoperatively) and approximately every 12 months thereafter as clinically indicated. Results: Of 191 eligible patients from 1/99 to 6/11, 67 (35%) met the inclusion criteria. The mean age was 67 years (42-90 years) with mean follow-up from the time of last CI at 43 months (12-149 months). A total of 283 three-dimensional US were performed, with the mean of 4 (2-11) per patient. The mean number of injections was 1.4 (1-3) with a mean injected volume at 5.8 mL(2-18 mL). The volume retention rate compared with the baseline volume was 84% (12%-100%), with a decrease in mean collagen volumes between the baseline and last follow-up visit (3.2 vs 2.7 mL; P = 0.008). Collagen volume decreased by a mean of 0.11 mL for each year past the final injection (P = 0.0015) by mixed-effect model analysis. Conclusions: Although believed to be nondurable, CI was found to be objectively stable over time by transvaginal 3D US in a subset of women with durably improved SUI symptoms.

AB - Objective: The aim of this study is to evaluate the durability of collagen injection (CI) using serial 3-dimensional (3D) transvaginal ultrasound (US) in women with sufficient improvement of stress urinary incontinence (SUI) symptoms not requiring additional treatment. Methods: After the institutional review board approval, a retrospective review of prospectively followed patients who underwent CI was conducted. Eligible patients received 3 or less consecutive CI for SUI with no reinjection afterward during the follow-up period and had a minimum follow-up of 1 year from the last CI. Serial 3D US was obtained for collagen volume and configuration at baseline (6-8 weeks postoperatively) and approximately every 12 months thereafter as clinically indicated. Results: Of 191 eligible patients from 1/99 to 6/11, 67 (35%) met the inclusion criteria. The mean age was 67 years (42-90 years) with mean follow-up from the time of last CI at 43 months (12-149 months). A total of 283 three-dimensional US were performed, with the mean of 4 (2-11) per patient. The mean number of injections was 1.4 (1-3) with a mean injected volume at 5.8 mL(2-18 mL). The volume retention rate compared with the baseline volume was 84% (12%-100%), with a decrease in mean collagen volumes between the baseline and last follow-up visit (3.2 vs 2.7 mL; P = 0.008). Collagen volume decreased by a mean of 0.11 mL for each year past the final injection (P = 0.0015) by mixed-effect model analysis. Conclusions: Although believed to be nondurable, CI was found to be objectively stable over time by transvaginal 3D US in a subset of women with durably improved SUI symptoms.

KW - 3-dimensional ultrasound

KW - Bulking agents

KW - Collagen

KW - Urethral injection

KW - Urinary incontinence

UR - http://www.scopus.com/inward/record.url?scp=84927621557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927621557&partnerID=8YFLogxK

U2 - 10.1097/SPV.0000000000000094

DO - 10.1097/SPV.0000000000000094

M3 - Article

C2 - 25185619

AN - SCOPUS:84927621557

VL - 21

SP - 25

EP - 29

JO - Female Pelvic Medicine and Reconstructive Surgery

JF - Female Pelvic Medicine and Reconstructive Surgery

SN - 2151-8378

IS - 1

ER -